| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | NEUTRAL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 16.69▲ | 16.77▼ | 16.83▼ | 16.43▲ | 16.10▲ |
| MA10 | 16.69▲ | 16.88▼ | 16.87▼ | 16.29▲ | 15.21▲ |
| MA20 | 16.73▼ | 16.87▼ | 16.79▼ | 16.18▲ | 15.88▲ |
| MA50 | 16.85▼ | 16.66▲ | 16.33▲ | 15.24▲ | 15.95▲ |
| MA100 | 16.88▼ | 16.28▲ | 16.29▲ | 16.00▲ | 14.50▲ |
| MA200 | 16.80▼ | 16.31▲ | 15.81▲ | 16.75▼ | 11.48▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.007▲ | -0.049▼ | -0.036▼ | 0.031▲ | 0.127▲ |
| RSI | 44.533▼ | 45.770▼ | 53.283▲ | 59.827▲ | 56.182▲ |
| STOCH | 43.151 | 16.581▼ | 42.746 | 62.604 | 66.275 |
| WILL %R | -21.053▲ | -84.375▼ | -71.053 | -22.989▲ | -27.527 |
| CCI | 95.381 | -134.133▼ | -98.259 | 135.299▲ | 101.671▲ |
| MA | $NMRK Price Crossed Below MA(200) | Set Alert |
|
Saturday, May 09, 2026 08:33 PM
Merck (NYSE:MRK) reported progress on its investigational oral PCSK9 inhibitor, enlicitide decanoate, including a biocatalytic large-scale manufacturing method. The company highlighted this new ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 08/05/26 | 16.91 | 17.13 | 16.65 | 16.73 | 1,278,701 |
| 07/05/26 | 16.61 | 16.885 | 16.569 | 16.87 | 1,189,832 |
| 06/05/26 | 16.56 | 16.82 | 16.55 | 16.60 | 1,340,881 |
| 05/05/26 | 15.67 | 16.35 | 15.58 | 16.33 | 1,622,267 |
| 04/05/26 | 15.85 | 16.21 | 15.43 | 15.64 | 2,032,993 |
| 01/05/26 | 16.34 | 16.645 | 15.96 | 16.04 | 2,973,036 |
| 30/04/26 | 15.91 | 16.28 | 15.39 | 16.12 | 2,591,459 |
| 29/04/26 | 16.23 | 16.3182 | 15.695 | 15.77 | 1,144,361 |
| 28/04/26 | 16.54 | 16.72 | 16.23 | 16.41 | 1,107,194 |
| 27/04/26 | 16.04 | 16.62 | 16.00 | 16.42 | 1,581,850 |
|
|
||||
|
|
||||
|
|